Zai Lab (Shanghai) Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   DLLEVATE · ZL-1310 Versus Investigator's Choice of Therapy…DLLEVATE · ZL-1310 Versus Investigator's Choice of Therapy · Relapsed Small Cell Lung Cancer (DLLEVATE)

   Trial sites expanded: 155 → 165 locations

   Zai Lab (Shanghai) Co., Ltd.·Phase 3· NCT07218146· Registry history of NCT07218146 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Minor

   ZL-1310 · Small Cell Lung Cancer

   Trial sites expanded: 38 → 41 locations

   Zai Lab (Shanghai) Co., Ltd.·Phase 1· NCT06179069· Registry history of NCT06179069 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.